Literature DB >> 2393952

Synthesis and biological evaluation of quinocarcin derivatives.

H Saito1, S Kobayashi, Y Uosaki, A Sato, K Fujimoto, K Miyoshi, T Ashizawa, M Morimoto, T Hirata.   

Abstract

Cyanation of quinocarcin readily opened the oxazolidine ring to provide DX-52-1 (2), which was a key compound in the synthesis of quinocarcin derivatives. Various electrophilic reactions toward aromatic ring of DX-52-1 were examined, and 10-substituted (e.g., halogen, nitro, formyl, cyano, hydroxy, etc.) analogs were prepared. Dehydrocyanation of the derivatives could be achieved to reproduce the oxazolidine ring upon treatment with HCl or AgNO3. 10-Chloride 10 and 10-bromide 11 were the most promising among the derivatives prepared. Antitumor activity of 10 was extended to B-16 melanoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393952     DOI: 10.1248/cpb.38.1278

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  1 in total

1.  Disposition of DX-52-1, a novel anticancer agent, after intravenous administration to mice and dogs.

Authors:  E Fuse; H Nishiie; H Kobayashi; S Ikeda; H Saito; J Covey; S Kobayashi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.